5593-2351 Screening compound: 3-{[3-(4-benzylpiperazin-1-yl)propyl]amino}-1-(4-propoxyphenyl)pyrrolidine-2,5-dione

5593-2351 Screening compound: 3-{[3-(4-benzylpiperazin-1-yl)propyl]amino}-1-(4-propoxyphenyl)pyrrolidine-2,5-dione
5593-2351 Screening compound: 3-{[3-(4-benzylpiperazin-1-yl)propyl]amino}-1-(4-propoxyphenyl)pyrrolidine-2,5-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound 5593-2351
3-{[3-(4-benzylpiperazin-1-yl)propyl]amino}-1-(4-propoxyphenyl)pyrrolidine-2,5-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5593-2351

Molecular Formula

C27H36N4O3 (C27 H36 N4 O3)

Compound Name

3-{[3-(4-benzylpiperazin-1-yl)propyl]amino}-1-(4-propoxyphenyl)pyrrolidine-2,5-dione

IUPAC name

3-{[3-(4-benzylpiperazin-1-yl)propyl]amino}-1-(4-propoxyphenyl)pyrrolidine-25-dione

SMILES

CCCOc(cc1)ccc1N(C(CC1NCCCN2CCN(Cc3ccccc3)CC2)=O)C1=O

InChI

InChI=1S/C27H36N4O3/c1-2-19-34-24-11-9-23(10-12-24)31-26(32)20-25(27(31)33)28-13-6-14-29-15-17-30(18-16-29)21-22-7-4-3-5-8-22/h3-5,7-12,25,28H,2,6,13-21H2,1H3/t25-/m0/s1

InChI Key

PRGMZPRTYSDCJM-VWLOTQADSA-N

MDL Number (MFCD)

MFCD03487321

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.888

Distribution Coefficient, logD

1.491

Water Solubility, LogSw

-2.44

Polar Surface Area

55.691

Acid Dissociation Constant (pKa)

17.23

Base Dissociation Constant (pKb)

7.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.10

5593-2351 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 5593-2351 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5593-2351?
Check Price and Availability of 5593-2351, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5593-2351 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5593-2351
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5593-2351
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5593-2351 available by request